APAN SCIENCE AND TECHNOLOGY AGENCY HOME PRESTO Understanding Life by iPS Cells Technology
Japanese
Mail toLink
HOME > Phase II (Noemi Fusaki) Research Theme
Research Area Research Supervisor/Deputy Research Supervisor/Research Advisor Researcher/Results News Office
Phase I
Phase II
Phase III

Researchers (Phase I)

3-years research type： Jiyoung Lee Hiroshi Kataoka Akira Kurisaki Akira Satoh
Go Nagamatsu Kyoji Horie Arata Honda Tetsuro Watabe
5-years research type： Masatsugu Ema Noemi Fusaki Yasuhide Ohinata  

Noemi Fusaki

Generation of safe iPS cells and cell differentiation by Sendai virus vectors

photo Noemi Fusaki

Researcher
PRESTO, JST/
Project Associate Professor
Ophthalmology, Keio University School of Medicine

Sendai virus (SeV) vector is a cytoplasmic RNA virus vector developed in Japan. Using the SeV vectors, we succeeded in the efficient generation of transgene-free human iPS cells. In this study, I will improve the technology to generate iPS cells more easily, and apply the cytoplasmic SeV vectors for the method of cell differentiation in order to accelerating the application of these 'safe' cells without chromosomal damage for the future regenerative medicine.

.

 

Homepage URL:http://www.dnavec.co.jp/

To Results
Mail to Office